Full history for every metric is available with a Kvantra account
Titan Medical Inc. (TMD.TO)
Key financial summary
Financials in USD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||
|---|---|---|---|---|---|---|---|
| Total revenue | $m | 0 | 0 | 20 | 20 | 0 | 18 |
| Operating profit | $m | 5 | |||||
| Net profit | $m | -23 | -42 | -25 | -15 | -43 | 7 |
| EPS reported | $ | 0.06 | |||||
| Operating cashflow per share | $ | 0.04 | |||||
| Capex per share | $ | 0.00 | |||||
| FCF per share | $ | 0.04 | |||||
| Free cash flow | $m | 4 | |||||
| Net debt | $m | -8 | |||||
| Book value equity | $m | 5 | |||||
| Book value per share | $ | 0.04 | |||||
| Number of shares | m | 116.84 | |||||
| DPS (TTM paid) | $ | 0.00 |
Financial summary
Financials in USD| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||
|---|---|---|---|---|---|---|---|
| Value | |||||||
| P/E TTM | x | 25.15 | |||||
| P/B LTM | x | 35.64 | |||||
| P/S LTM | x | 9.67 | |||||
| P/FCF LTM | x | 38.16 | |||||
| EV/EBITDA LTM | x | 22.25 | |||||
| EV/Sales LTM | x | 9.32 | |||||
| Earnings Yield LTM | % | 3.98% | |||||
| FCF Yield | % | 2.62% | |||||
| Quality | |||||||
| ROE | % | 145.31% | |||||
| ROIC | % | 78.95% | |||||
| Operating margin | % | 27.44% | |||||
| Gross margin | % | 100.00% | |||||
| FCF/Sales | % | 25.34% | |||||
| Growth and momentum | |||||||
| EPS Growth YoY | % | - | |||||
| Sales Growth YoY | % | - | |||||
| Net Income Growth YoY | % | - | |||||
| FCF Growth | % | - | |||||
| Operating Profit Growth | % | - | |||||
| Dividend and capital structure | |||||||
| Dividend Yield | % | 0.00% | |||||
| Dividend Growth | % | 0.00% | |||||
| Payout Ratio | % | 0.00% | |||||
| FCF/Debt | x | 3.38 | |||||
| Net Debt/EBITDA | x | -0.84 | |||||
| EBIT/Net interest | x | 21.90 | |||||
| Net debt/market cap | % | -4.42% | |||||
| Net debt/Equity | x | -1.58 | |||||
| Gross debt/equity | x | 0.28 | |||||
Company overview
Titan Medical Inc. is a medical technology firm specializing in creating and marketing robotic systems designed for minimally invasive surgical procedures. The company's primary innovation is the Enos system, an advanced single-port robotic surgical platform. This system comprises a surgeon-operated patient cart, equipped with a high-definition 3D visualization system and highly dexterous, multi-articulating surgical tools. Complementing this is a surgeon workstation, which offers an ergonomic control interface for the patient cart and provides the surgeon with a comprehensive 3D endoscopic view of the internal surgical site during operations. Its corporate headquarters are located in Toronto, Canada.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Titan Medical Inc. (TMD.TO)
Titan Medical Inc. is a medical technology firm specializing in creating and marketing robotic systems designed for minimally invasive surgical procedures. The company's primary innovation is the Enos system, an advanced single-port robotic surgical platform. This system comprises a surgeon-operated patient cart, equipped with a high-definition 3D visualization system and highly dexterous, multi-articulating surgical tools. Complementing this is a surgeon workstation, which offers an ergonomic control interface for the patient cart and provides the surgeon with a comprehensive 3D endoscopic view of the internal surgical site during operations. Its corporate headquarters are located in Toronto, Canada.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free